LILACS – Literatura Latinoamericana y del Caribe de Ciencias de la Salud | LILACS

Results: 410

Manifestaciones neuropsiquiátricas del lupus eritematoso sistémico: revisión bibliográfica

Rev. méd. Maule; 38 (1), 2023
Neuropsychiatric syndromes in systemic lupus erythematosus (SLE) are one of the many clinical manifestations in which this pathology presents. They have a wide range of prevalence, from 37- 95% due to factors like absence of standardized definitions and non-nespecific clinical manifestations. Physiopatho...

Lupus eritematoso sistémico pediátrico asociado a hepatitis autoinmune y síndrome nefrítico: Reporte de un caso y revisión de la literatura

Rev. ecuat. pediatr; 24 (1), 2023
Introducción: El lupus eritematoso sistémico (LES) es una enfermedad autoinmune que puede afectar a múltiples órganos. Las patologías asociadas como: la hepatitis y la nefritis lúpica no son frecuentes en la población infantil, pero conllevan a consecuencias graves con riesgo de insuficiencia hepÃ...

Association of Fokl polymorphism of the VDR gene with systemic lupus erythematosus in an adolescent population of the Colombian Caribbean

Rev. colomb. reumatol; 30 (1), 2023
Introduction: Vitamin D and vitamin D receptor (VDR) polymorphisms are associated with autoimmune diseases including systemic lupus erythematosus (SLE). The aim of this study is to assess the genetic association between VDR polymorphisms: TaqI, ApaI, Bsml and FokI and SLE with serum levels of Vitamin D i...

Pseudo-obstruction, an infrequent Lupus manifestation: A case report

Rev. colomb. reumatol; 30 (1), 2023
Gastrointestinal involvement in SLE has been reported in up to 50%, generally secondary to the adverse effects of treatment. Intestinal pseudo-obstruction is caused by hypomotility related to ineffective propulsion. The case of a 51-year-old patient with intestinal obstruction is presented. She was taken...

Factores de riesgo de hospitalización y mortalidad de pacientes internados con lupus eritematoso sistémicoen Paraguay
Hospitalization and mortality risk factors of patients with systemic lupus erythematoso in Paraguay

Introducción. La internación de pacientes con lupus eritematoso sistémico (LES) es frecuente. Objetivo. Determinar los factores de riesgo de internación y mortalidad en pacientes con LES internados en el Hospital Nacional de enero del 2016 a diciembre 2019. Metodología. Estudio observaciona...

Toll-like receptor 9 polymorphisms in brazilian patients with systemic lupus erythematosus: a pilot study

Braz. j. biol; 83 (), 2023
Abstract Toll-like receptor 9 (TLR9) is an important component of the innate immune system and have been associated with several autoimmune diseases, such as Systemic Lupus Erythematosus (SLE). The aim of this study was to investigate polymorphisms in TLR9 gene in a Brazilian SLE patients group and their...

Anal cancer in systemic lupus erythematosus patients is a neglected condition

Patients with systemic lupus erythematosus have a higher incidence of neoplasms associated with human papillomavirus infections, such as those that affect the vulva, the vagina, and the cervix; however, little is known about the frequency of anal cancer among these patients. Although there are recommenda...

Cell phenotypes as activity biomarkers in patients with Systemic Lupus Erythematosus

Abstract The pathogenesis of systemic lupus erythematosus (SLE) is complex. Few studies in Brazilian population have addressed cell phenotypes associated with immunological responses and their associations with SLE activity. The aim of this study is to investigate cell phenotypes associated to SLE diagno...

Obstetric and Perinatal Outcomes in Pregnant Women with Lupus: Retrospective Study in a Portuguese Tertiary Center

Abstract Objective Pregnancy in women with lupus poses a higher risk of complications compared with the general population. The present study aimed to determine and describe the obstetric and neonatal outcomes of pregnant women with lupus. Materials and Methods We conducted an observational retrospecti...

Impact of baseline fluorescent antinuclear antibody positivity on the clinical outcome of patients with primary autoimmune hemolytic anemia

Abstract Introduction Autoimmune haemolytic anaemia (AIHA) is an autoimmune disorder that can present in primary or secondary forms. The literature looking at impact of baseline fluorescent antinuclear antibody (FANA) positivity on outcomes of AIHA patients is infrequent. Objective To study the impact ...